QUELLTX INC

Cambridge, MA · Biotech · Private

BRITE platform—a high-throughput all-optical physiology system for single-cell and single-action-potential resolution measurement in human neurons, integrated with CRISPR screening and machine learnin

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: Cambridge, MA
Total capital: $10.7M

Federal grants: $10.7M; 5 awards · 2020–2023; Rank in peer group#2 of 18
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 4 pending · first 2024; Rank in peer group#4 of 18

Capital timeline

Latest events

Sep 2023Federal grantHealth and Human S · Phase II · BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning$1.7M
Sep 2022Federal grantHealth and Human S · Phase II · Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology$3.7M
Aug 2022Federal grantHealth and Human S · Phase II · A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling$1.6M
Jul 2022Federal grantHealth and Human S · Phase II · Functional drug fingerprinting with all-optical electrophysiology$2.1M
Sep 2020Federal grantHealth and Human S · Phase II · A phenotypic screen for osteoarthritic pain therapeutics using all-optical electrophysiology.$1.6M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 18 peers

Line = median

Biotech · Device

Federal grants#2 · top 11%
Granted patents#4 · top 22%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 6

May 22, 2025PendingTherapeutic Compositions For Treating Pain Via Multiple TargetsUSPTOApplication 18958374
Nov 26, 2024GrantedTherapeutic Compositions For Treating Pain Via Multiple TargetsUSPTOUS 12,152,243
Oct 1, 2024GrantedMulti-well Plate Readers And Methods Of Their UseUSPTOUS 12,105,023

Show all 6 patent records

Therapeutic Compositions For Treating Pain Via Multiple TargetsMay 22, 2025 · Application 18958374Pending
Therapeutic Compositions For Treating Pain Via Multiple TargetsNov 26, 2024 · US 12,152,243Granted
Multi-well Plate Readers And Methods Of Their UseOct 1, 2024 · US 12,105,023Granted
Therapeutics For Haploinsufficiency ConditionsJul 6, 2023 · Application 17934428Pending
Drug FingerprintingNov 10, 2022 · Application 17735782Pending
UBE3A Antisense TherapeuticsAug 18, 2022 · Application 17674692Pending

Q-State Biosciences, Inc.Shares a founder: LUIS WILLIAMS
SpliceBioSimilar federal contract value in Biotech · null in contracts
SOUTHEASTERN BIOCHEMICALS, INC.Similar federal contract value in Biotech · null in contracts
ANOVIA, LLCSimilar federal contract value in Biotech · null in contracts
Sidewinder TherapeuticsSimilar federal contract value in Biotech · null in contracts
BIOPROVAR CORPORATIONSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.